# Batch 3 Synthetic World-Level File Construction Ratification

World: Korvin Merrow

Artifact set: Batch 3 Synthetic World-Level Files

Files locked:

- `worlds/korvin-merrow/synthetic-files/locked/batch-3/FI-W14_nephrology-consultation-documentation.md`
- `worlds/korvin-merrow/synthetic-files/locked/batch-3/FI-W15_cardiology-consultation-documentation.md`
- `worlds/korvin-merrow/synthetic-files/locked/batch-3/FI-W16_endocrinology-consultation-documentation.md`
- `worlds/korvin-merrow/synthetic-files/locked/batch-3/batch-3-validation-review.md`

## Review Outcome

Status: LOCKED

Batch 3 Construction status: COMPLETE

Review verdicts:

- Claude Code Review: YES / LOCK READY / GO
- Windsurf Claude Review: YES / LOCK READY / GO

No true defects were identified. No blockers were identified.

## Ratification Findings

- FI-W14 through FI-W16 validate against the locked File Inventory rows.
- Nephrology consultation is clinically defensible.
- Cardiology consultation is clinically defensible.
- Endocrinology consultation is clinically defensible.
- Cardiology vs Nephrology remains a timing and sequencing friction.
- Neither Cardiology nor Nephrology is obviously correct or careless.
- Neither Cardiology nor Nephrology becomes the final medication-restart authority.
- Endocrinology remains interpretive.
- Adrenal insufficiency is not proven.
- Steroid risk remains meaningful but not dominant.
- Prednisone hierarchy is preserved, with Rheumatology as the highest outpatient taper authority.
- Consultant notes remain interpretation sources, not source-of-truth overrides.
- Hospitalist-synthesizes-not-defers governance is preserved.
- FI-W12 values are cited consistently.
- FI-W13 MAR/action source is not converted into a final medication plan.
- Insulin lispro remains inpatient-only.
- No answer-file drift was identified.
- No post-world leakage was identified.
- Batch 1 and Batch 2 consistency is preserved.

## Accepted Carry-Forward Items

- Batch 4 must carry buried functional and cognitive evidence.
- Batch 4 must preserve Trap #3 as buried-but-discoverable evidence.
- Batch 4 must preserve the Trap #3 vs Trap #5 distinction.
- FI-W20 family communication must not make discharge obviously unsafe by itself.
- FI-W22 later must remain visible-but-incomplete and must not duplicate or resolve all consultant caveats.
- Later files must not let Endocrinology replace Rheumatology as prednisone-history source of truth.
- Later files must not let either consultant become the final medication authority.

## Boundary Record

Batch 3 lock does not authorize creation of FI-W17 through FI-W22, task-level files, supplementary files, task prompts, expected outputs, golden responses, grader guidance, AutoQC responses, DOCX artifacts, submission materials, Studio packaging, or RL Studio upload.

Next eligible phase: Batch 4 Synthetic World-Level File Construction.
